TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

Growing evidence suggests that the key to treating Alzheimer's is catching it in its earliest stages. Now scientists have ...

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

Explore the potential of experimental drug NU-9 in early Alzheimer's intervention, targeting toxic amyloid beta forms.

ME/CFS is a neurological condition characterized by malaise. Diagnosis requires ruling out other systemic illnesses.

Innovative single-device solution integrates proven FemVue and FemChec® technologies to support fallopian tube evaluation and improve workflow ...

The 28-year-old describes the warning signs as 'clear indicators' that something wasn't quite right with her mother, but ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Huxley Medical, Inc. announced the SANSA(R) home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...

Cui, J.X., Liu, K.H. and Liang, X.J. (2026) A Brief Discussion on the Theory and Application of Artificial Intelligence in ...

Background Out-of-hours primary care (OOH-PC) services are complex clinical environments where suboptimal care may occur.

Compared with white patients, Black patients with an aggressive form of leukemia—called acute myeloid leukemia (AML)—were on ...